• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Synthetic lethal screening identifies DHODH as a target for MEN1-mutated tumor cells.

作者信息

Ma Yarui, Zhu Qing, Wang Xiaobing, Liu Mei, Chen Qichen, Jiang Liming, Chi Yihebali, Zeng Yi-Xin, Zhao Hong, Jiao Yuchen

机构信息

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Department of Medical Oncology, Beijing Hospital, National Center of Gerontology and Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Cell Res. 2022 Jun;32(6):596-599. doi: 10.1038/s41422-022-00613-1. Epub 2022 Feb 15.

DOI:10.1038/s41422-022-00613-1
PMID:35169281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9160065/
Abstract
摘要

相似文献

1
Synthetic lethal screening identifies DHODH as a target for MEN1-mutated tumor cells.合成致死筛选确定二氢乳清酸脱氢酶（DHODH）为MEN1突变肿瘤细胞的一个靶点。
Cell Res. 2022 Jun;32(6):596-599. doi: 10.1038/s41422-022-00613-1. Epub 2022 Feb 15.
2
Protein S-glutathionylation and sex dimorphic effects on hydrogen peroxide production by dihydroorotate dehydrogenase in liver mitochondria.蛋白质S-谷胱甘肽化及肝脏线粒体中二氢乳清酸脱氢酶产生过氧化氢的性别差异效应。
Free Radic Biol Med. 2023 Jan;194:123-130. doi: 10.1016/j.freeradbiomed.2022.11.043. Epub 2022 Nov 30.
3
Identification of Dihydroorotate Dehydrogenase Inhibitors─Indoluidins─That Inhibit Cancer Cell Growth.鉴定二氢乳清酸脱氢酶抑制剂——吲唑类化合物——抑制癌细胞生长。
ACS Chem Biol. 2021 Nov 19;16(11):2570-2580. doi: 10.1021/acschembio.1c00625. Epub 2021 Nov 3.
4
Inhibition of mitochondrial complex III or dihydroorotate dehydrogenase (DHODH) triggers formation of poly(A) RNA foci adjacent to nuclear speckles following activation of ATM (ataxia telangiectasia mutated).抑制线粒体复合物 III 或二氢乳清酸脱氢酶（DHODH）会在 ATM（共济失调毛细血管扩张突变）激活后触发多聚（A）RNA 焦点在核斑点附近的形成。
RNA Biol. 2022 Jan;19(1):1244-1255. doi: 10.1080/15476286.2022.2146919.
5
Protein-lipid interactions of human dihydroorotate dehydrogenase and three mutants associated with Miller syndrome.人类二氢乳清酸脱氢酶及与米勒综合征相关的三个突变体的蛋白质-脂质相互作用
Nucleosides Nucleotides Nucleic Acids. 2022;41(12):1337-1358. doi: 10.1080/15257770.2022.2039393. Epub 2022 Feb 20.
6
SAR studies toward discovery of emvododstat (PTC299), a potent dihydroorotate dehydrogenase (DHODH) inhibitor.关于发现强效二氢乳清酸脱氢酶（DHODH）抑制剂emvododstat（PTC299）的构效关系研究。
Eur J Med Chem. 2022 Dec 15;244:114826. doi: 10.1016/j.ejmech.2022.114826. Epub 2022 Oct 5.
7
Manganese induces tumor cell ferroptosis through type-I IFN dependent inhibition of mitochondrial dihydroorotate dehydrogenase.锰通过I型干扰素依赖性抑制线粒体二氢乳清酸脱氢酶诱导肿瘤细胞铁死亡。
Free Radic Biol Med. 2022 Nov 20;193(Pt 1):202-212. doi: 10.1016/j.freeradbiomed.2022.10.004. Epub 2022 Oct 10.
8
A first in man study to evaluate the safety, pharmacokinetics and pharmacodynamics of RP7214, a dihydroorotate dehydrogenase inhibitor in healthy subjects.一项在健康受试者中评估二氢乳清酸脱氢酶抑制剂 RP7214 的安全性、药代动力学和药效学的首次人体研究。
Br J Clin Pharmacol. 2023 Mar;89(3):1127-1138. doi: 10.1111/bcp.15562. Epub 2022 Nov 1.
9
DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma.DHODH 是神经母细胞瘤的一个独立预后标志物和有效治疗靶点。
JCI Insight. 2022 Aug 9;7(17):e153836. doi: 10.1172/jci.insight.153836.
10
-Heterocyclic 3-Pyridyl Carboxamide Inhibitors of DHODH for the Treatment of Acute Myelogenous Leukemia.用于治疗急性髓性白血病的 DHODH 的杂环 3-吡啶甲酰胺抑制剂。
J Med Chem. 2022 Aug 25;65(16):11241-11256. doi: 10.1021/acs.jmedchem.2c00788. Epub 2022 Aug 4.

引用本文的文献

1
Progress report on multiple endocrine neoplasia type 1.1型多发性内分泌肿瘤的进展报告
Fam Cancer. 2025 Jan 18;24(1):15. doi: 10.1007/s10689-025-00440-4.
2
Sporadic Parathyroid Carcinoma Treated With Lenvatinib, Exhibiting a Novel Somatic Mutation.用乐伐替尼治疗的散发性甲状旁腺癌，表现出一种新的体细胞突变。
JCEM Case Rep. 2024 Jul 24;2(8):luae121. doi: 10.1210/jcemcr/luae121. eCollection 2024 Aug.
3
Successful management of a multiple endocrine neoplasia type 1-associated thymic neuroendocrine neoplasms with acute chest pain as initial symptom: A rare case report.以急性胸痛为首发症状的1型多发性内分泌腺瘤病相关胸腺神经内分泌肿瘤的成功管理：一例罕见病例报告。
Clin Case Rep. 2024 Jun 14;12(6):e9031. doi: 10.1002/ccr3.9031. eCollection 2024 Jun.
4
Dehydroabietylamine exerts antitumor effects by affecting nucleotide metabolism in gastric cancer.去氢枞胺通过影响核苷酸代谢发挥胃癌的抗肿瘤作用。
Carcinogenesis. 2024 Oct 10;45(10):759-772. doi: 10.1093/carcin/bgae037.
5
Classical swine fever virus non-structural protein 4A recruits dihydroorotate dehydrogenase to facilitate viral replication.经典猪瘟病毒非结构蛋白4A招募二氢乳清酸脱氢酶以促进病毒复制。
J Virol. 2024 Jun 13;98(6):e0049424. doi: 10.1128/jvi.00494-24. Epub 2024 May 17.
6
DHODH inhibition represents a therapeutic strategy and improves abiraterone treatment in castration-resistant prostate cancer.DHODH 抑制代表一种治疗策略，并可改善醋酸阿比特龙在去势抵抗性前列腺癌中的治疗效果。
Oncogene. 2024 May;43(19):1399-1410. doi: 10.1038/s41388-024-03005-4. Epub 2024 Mar 13.
7
Ferroptosis: a new hunter of hepatocellular carcinoma.铁死亡：肝细胞癌的新“猎手”
Cell Death Discov. 2024 Mar 13;10(1):136. doi: 10.1038/s41420-024-01863-1.
8
Recent research hotspots in sequencing and the pancreatic neuroendocrine tumor microenvironment.测序及胰腺神经内分泌肿瘤微环境的近期研究热点
Cancer Biol Med. 2023 Sep 28;20(10):721-7. doi: 10.20892/j.issn.2095-3941.2023.0284.
9
Small molecule inhibitors for cancer metabolism: promising prospects to be explored.小分子抑制剂在癌症代谢中的应用：具有广阔前景的探索。
J Cancer Res Clin Oncol. 2023 Aug;149(10):8051-8076. doi: 10.1007/s00432-022-04501-4. Epub 2023 Mar 31.
10
Optimization of CRISPR-Cas system for clinical cancer therapy.用于临床癌症治疗的CRISPR-Cas系统的优化
Bioeng Transl Med. 2022 Dec 23;8(2):e10474. doi: 10.1002/btm2.10474. eCollection 2023 Mar.